Skip to main content
. 2023 Apr 7;26(5):106582. doi: 10.1016/j.isci.2023.106582

Table 2.

Average fold increase of indicated antibody features for the respective VOC spike proteins from pre third dose to the post third dose timepoint

WT Alpha Beta Delta BA.1 BA.2
IgG1 486 584 512 560 213 187
IgA1 328 459 71 247 50 85
FcγR2a 3575 5388 4936 6658 2581 204
FcγR2b 6168 5725 5481 3392 1169 346
FcγR3a 1814 1365 713 1091 929 1216
FcγR3b 940 2426 642 2841 95 112